p53 Activation by Blocking Snail : A Novel Pharmacological Strategy for Cancer

E-ISSN： 1873-4286|17|6|610-617

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.6, 2011-02, pp. : 610-617

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Activation of p53 in Cancer Cells

Current Pharmaceutical Design, Vol. 17, Iss. 6, 2011-02 ,pp. : 631-639

Bentham Science Publishers

Access to resources Recommend Favorite

p53: Fighting Cancer

Current Cancer Drug Targets, Vol. 4, Iss. 5, 2004-08 ,pp. : 385-402

Bentham Science Publishers

Access to resources Recommend Favorite

Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells

By Oh Eun-Taex

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 435-442

Springer Publishing Company

Access to resources Recommend Favorite

Reactivation of p53 by Novel MDM2 Inhibitors: Implications for Pancreatic Cancer Therapy

Current Cancer Drug Targets, Vol. 10, Iss. 3, 2010-05 ,pp. : 319-331

Bentham Science Publishers

Access to resources Recommend Favorite

B1, a novel naphthalimide-based DNA intercalator, induces cell cycle arrest and apoptosis in HeLa cells via p53 activation

By Liang Xin

Investigational New Drugs, Vol. 29, Iss. 4, 2011-08 ,pp. : 646-658

Springer Publishing Company

Access to resources Recommend Favorite